immune disorders

A unique collection of 2400 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of 540 gut microbial metabolites which can be used for HTS and HCS;

A unique collection of 89 chemokines or chemokine receptors targeted compounds for high throughput and high content screening;

A unique collection of 415 JAK/STAT signaling targeted compounds for high throughput and high content screening;

A unique collection of 5293 anti-inflammation compounds effective for high throughput screening and high content screening.

A unique collection of 2300 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);

A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);

1323 compounds derived from heat-clearing and detoxifying TCM for HCS and HTS.

A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa

A unique collection of 2405 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);